← Product Code [KWP](/submissions/OR/subpart-d%E2%80%94prosthetic-devices/KWP) · K962984 # ISOLA PEDIATRIC COMPONENTS (K962984) _Acromed Corp. · KWP · Nov 27, 1996 · Orthopedic · SN_ **Canonical URL:** https://fda.innolitics.com/submissions/OR/subpart-d%E2%80%94prosthetic-devices/KWP/K962984 ## Device Facts - **Applicant:** Acromed Corp. - **Product Code:** [KWP](/submissions/OR/subpart-d%E2%80%94prosthetic-devices/KWP.md) - **Decision Date:** Nov 27, 1996 - **Decision:** SN - **Submission Type:** Traditional - **Regulation:** 21 CFR 888.3050 - **Device Class:** Class 2 - **Review Panel:** Orthopedic - **Attributes:** Therapeutic, Pediatric ## Intended Use When labeled for pedicle screw fixation, the ISOLA implants are intended for use in grade 3 or 4 spondylolisthesis at the fifth lumbar - first sacral vertebral (L5-S1) joint utilizing autologous bone graft and intended to be removed after solid fusion is attained. The ISOLA Spinal System, when not used with pedicle screws, is intended for hook, wire, and/or sacral/iliac screw fixation from T1 to the ilium/sacrum. The non-pedicle screw indications are spondylolisthesis, degenerative disc disease (defined as discogenic back pain with degeneration of the disc confirmed by history and radiographic studies), deformities (scoliosis, lordosis and kyphosis), tumor, fracture and previous failed surgery. As a whole, the ISOLA Spinal System is intended for T1-sacral fixation. Screw fixation is from L3-S1. ## Device Story Pediatric ISOLA components consist of downsized side-tightening hooks for spinal fixation in pediatric or small-stature patients. Used with existing ISOLA system components (3/16 inch rods, transverse connectors, wires, cables, screws). Implanted by surgeons during spinal fusion procedures to stabilize vertebrae. Provides mechanical support to facilitate bone fusion; intended for removal after fusion. Risks include component fracture, loss of fixation, non-union, or neurological/vascular injury. ## Clinical Evidence Bench testing only. Static and fatigue testing performed to compare constructs of ISOLA Pediatric Components against previously cleared ISOLA components, showing consistent performance. ## Technological Characteristics Materials: ASTM F-138 stainless steel. Components: side-tightening hooks, 3/16 inch diameter rods, transverse connectors, sublaminar wires/cables, dual/tandem connectors, slotted connectors, sacral/iliac screws. Mechanical fixation system. ## Regulatory Identification A spinal interlaminal fixation orthosis is a device intended to be implanted made of an alloy, such as stainless steel, that consists of various hooks and a posteriorly placed compression or distraction rod. The device is implanted, usually across three adjacent vertebrae, to straighten and immobilize the spine to allow bone grafts to unite and fuse the vertebrae together. The device is used primarily in the treatment of scoliosis (a lateral curvature of the spine), but it also may be used in the treatment of fracture or dislocation of the spine, grades 3 and 4 of spondylolisthesis (a dislocation of the spinal column), and lower back syndrome. ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0} k962984 1 of 2 # ISOLA SYSTEM ## ISOLA Pediatric Components ### 510(k) SUMMARY NOV 27 1996 **COMPANY:** AcroMed Corporation 3303 Carnegie Avenue Cleveland, OH 44115 **TRADENAME:** ISOLA Pediatric Components used with the ISOLA System **CLASSIFICATION:** Spinal interlaminal fixation orthosis Class II **DESCRIPTION:** The Pediatric ISOLA Components consist of side-tightening hooks with downsized dimensions to accommodate the anatomic limitations found where internal fixation is performed on pediatric or small stature individuals. The hooks are used with components already available in the ISOLA Spine System including 3/16 inch diameter rods, transverse connectors, sublaminar wires and cables, dual and tandem connectors, slotted connectors, sacral and iliac screws. **MATERIAL:** All implant components are manufactured of ASTM F-138 stainless steel. **INDICATIONS:** When labeled for pedicle screw fixation, the ISOLA implants are intended for use in grade 3 or 4 spondylolisthesis at the fifth lumbar - first sacral vertebral (L5-S1) joint utilizing autologous bone graft and intended to be removed after solid fusion is attained. Benefit of spinal fusions utilizing any pedicle screw fixation has not been adequately established in patients with stable spines. Potential risks identified with the use of this device system, which may require additional surgery, include: device component fracture, loss of fixation, non-union, fracture of the vertebra, neurological injury, and vascular or visceral injury. 77/6 12 0027 '97 WJH01F 0001 '97 11:00 {1} 2 cf.2 The ISOLA Spinal System, when not used with pedicle screws, is intended for hook, wire, and/or sacral/iliac screw fixation from T1 to the ilium/sacrum. The non-pedicle screw indications are spondylolisthesis, degenerative disc disease (defined as discogenic back pain with degeneration of the disc confirmed by history and radiographic studies), deformities (scoliosis, lordosis and kyphosis), tumor, fracture and previous failed surgery. As a whole, the ISOLA Spinal System is intended for T1-sacral fixation. Screw fixation is from L3-S1. Contraindications for the use of the ISOLA System include active systemic infection or infection localized to the site of the proposed implantation. Severe osteoporosis may prevent adequate fixation of spinal anchors and thus preclude the use of this or any other posterior spinal instrumentation system. Any entity or condition that totally precludes the possibility of fusion, i.e., cancer, kidney dialysis, or osteopenia are relative contraindications. Other relative contraindications include obesity, certain degenerative diseases, and foreign body sensitivity. In addition, the patient's occupation or activity level or mental capacity may be relative contraindications to this surgery. Specifically, patients because of their occupation or lifestyle, or because of conditions such as mental illness, alcoholism or drug abuse, may place undue stresses on the implant. ## PERFORMANCE DATA: Static and fatigue testing show the constructs of the ISOLA Pediatric Components to perform consistently with previously cleared components. ## SUBSTANTIAL EQUIVALENCE: The ISOLA Pediatric components are equivalent to other ISOLA Components in intended use and attachment. 77 2 12 2360 11 1 --- **Source:** [https://fda.innolitics.com/submissions/OR/subpart-d%E2%80%94prosthetic-devices/KWP/K962984](https://fda.innolitics.com/submissions/OR/subpart-d%E2%80%94prosthetic-devices/KWP/K962984) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com